Gottlieb Outlines FDA’s Approach to Precision Medicines in Davos

FDA Commissioner Scott Gottlieb spoke about the regulatory challenges of precision medicines and the agency’s plans to focus on durability and safety issues, in a panel discussion at the World Economic Forum in Davos, Switzerland.
Source: Drug Industry Daily